Clinical Trial Update: Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety and tolerability of secukinumab in patients with rheumatoid arthritis who are on methotrexate; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02